WallStSmart

Unilever PLC ADR (UL)vsUSANA Health Sciences Inc (USNA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Unilever PLC ADR generates 5358% more annual revenue ($50.50B vs $925.26M). UL leads profitability with a 18.8% profit margin vs 1.2%. USNA appears more attractively valued with a PEG of 0.81. USNA earns a higher WallStSmart Score of 54/100 (C-).

UL

Hold

46

out of 100

Grade: D+

Growth: 2.0Profit: 8.5Value: 4.3Quality: 5.0

USNA

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 5.0Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for UL.

USNAUndervalued (+73.0%)

Margin of Safety

+73.0%

Fair Value

$77.70

Current Price

$19.05

$58.65 discount

UndervaluedFair: $77.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

UL4 strengths · Avg: 8.8/10
Return on EquityProfitability
31.0%10/10

Every $100 of equity generates 31 in profit

Market CapQuality
$128.81B9/10

Large-cap with strong market position

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

Free Cash FlowQuality
$5.48B8/10

Generating 5.5B in free cash flow

USNA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

PEG RatioValuation
0.818/10

Growing faster than its price suggests

Areas to Watch

UL3 concerns · Avg: 2.0/10
PEG RatioValuation
11.152/10

Expensive relative to growth rate

Revenue GrowthGrowth
-3.2%2/10

Revenue declined 3.2%

EPS GrowthGrowth
-3.4%2/10

Earnings declined 3.4%

USNA4 concerns · Avg: 3.3/10
P/E RatioValuation
33.7x4/10

Premium valuation, high expectations priced in

Market CapQuality
$360.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : UL

The strongest argument for UL centers on Return on Equity, Market Cap, Operating Margin. Profitability is solid with margins at 18.8% and operating margin at 20.1%.

Bull Case : USNA

The strongest argument for USNA centers on Price/Book, PEG Ratio. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : UL

The primary concerns for UL are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : USNA

The primary concerns for USNA are P/E Ratio, Market Cap, Return on Equity. Thin 1.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

UL profiles as a declining stock while USNA is a value play — different risk/reward profiles.

USNA carries more volatility with a beta of 0.70 — expect wider price swings.

USNA is growing revenue faster at 5.9% — sustainability is the question.

UL generates stronger free cash flow (5.5B), providing more financial flexibility.

Bottom Line

USNA scores higher overall (54/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Unilever PLC ADR

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Unilever PLC is a fast moving consumer goods company in Asia, Africa, the Middle East, Turkey, Russia, Ukraine, Belarus, America and Europe. The company is headquartered in London, the United Kingdom.

USANA Health Sciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.

Want to dig deeper into these stocks?